Samilia Obeng-Gyasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samilia Obeng-Gyasi has a total of 238 co-authors. Here are the top co-authors by number of shared publications:
- Jesus D. Anampa
Department of Medical Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York
29 shared publications - J. C. Chen
Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH
27 shared publications - Jesse J. Plascak
Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
20 shared publications - Mohamed I. Elsaid
Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH
20 shared publications - Demond Handley
The Ohio State University
19 shared publications Mohamed I. Elsaid
12 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 263
Association between postoperative complications and recurrence-free survival in patients with hormone receptor-positive, HER2 negative breast cancer
- 17 October 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 263
Open AccessAssociation between postoperative complications and recurrence-free survival in patients with hormone receptor-positive, HER2 negative breast cancer
- 13 October 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
Promoting High-Quality, Accessible Cancer Care for People With Disabilities
People with disabilities (PWD) face numerous challenges throughout the continuum of cancer care. Many of these are due to personal and structural biases that have historically made it more difficult for PWD to access oncologic care and which can be dehumanizing. We provide a narrative review of these challenges, starting with a review of disability statistics and methodologic considerations when reviewing the epidemiology of disability. We then discuss historic legal frameworks designed to support PWD, and barriers to oncology care faced by PWD, organized around the following primary topics: (1) biases faced by PWD from health care professionals, (2) screening, (3) diagnosis, (4) treatment, (5) survivorship, and (6) historical exclusion from oncology research. We conclude by identifying key areas that must be addressed to provide high-quality oncologic care for PWD. A variety of suggestions for addressing these issues are presented, including additional education of oncology providers, rethinking performance status, engaging stakeholders in the disability community, improving enrollment in clinical trials for PWD, and collecting consistent disability-related data.
- 13 October 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
Promoting High-Quality, Accessible Cancer Care for People With Disabilities
People with disabilities (PWD) face numerous challenges throughout the continuum of cancer care. Many of these are due to personal and structural biases that have historically made it more difficult for PWD to access oncologic care and which can be dehumanizing. We provide a narrative review of these challenges, starting with a review of disability statistics and methodologic considerations when reviewing the epidemiology of disability. We then discuss historic legal frameworks designed to support PWD, and barriers to oncology care faced by PWD, organized around the following primary topics: (1) biases faced by PWD from health care professionals, (2) screening, (3) diagnosis, (4) treatment, (5) survivorship, and (6) historical exclusion from oncology research. We conclude by identifying key areas that must be addressed to provide high-quality oncologic care for PWD. A variety of suggestions for addressing these issues are presented, including additional education of oncology providers, rethinking performance status, engaging stakeholders in the disability community, improving enrollment in clinical trials for PWD, and collecting consistent disability-related data.
- 24 March 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
Opportunities and challenges for addressing financial hardship as an integrated part of cancer care delivery
The National Cancer Institute (NCI) awarded administrative supplements to 11 NCI-designated cancer centers to build capacity for financial navigation services and collect preliminary data to implement and evaluate financial navigation programs. Preliminary findings from the projects were shared during a virtual conference in October 2022. This paper reflects major themes from the conference, the now completed projects, and findings from scientific literature to propose a set of recommendations for addressing financial hardship as part of cancer care delivery. Recommendations include the following principles. Healthcare systems should implement financial hardship screening using validated, culturally appropriate tools, considering patient literacy and language needs. Screening programs should be universal with assessments repeated over time. Financial navigation services should be available to help patients manage direct and indirect costs of care, access financial assistance and navigate employment-related challenges. Financial navigators should receive specialized training to build their knowledge of healthcare billing, insurance, financial assistance, and patient advocacy while also preparing them to support patients and leverage local and regional resources. A multidisciplinary care team approach should be applied to developing and implementing financial hardship screening and navigation services. Finally, health systems should harmonize information technology and workflows across departments involved in screening and financial navigation service delivery and automate screening, referral, and care team notification processes. Future research should address outstanding knowledge gaps, including the optimal interval for screening, how to identify patient needs early to mitigate downstream financial hardship, and the ideal components and timing of financial navigation for different settings and populations.
- 24 March 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
Opportunities and challenges for addressing financial hardship as an integrated part of cancer care delivery
The National Cancer Institute (NCI) awarded administrative supplements to 11 NCI-designated cancer centers to build capacity for financial navigation services and collect preliminary data to implement and evaluate financial navigation programs. Preliminary findings from the projects were shared during a virtual conference in October 2022. This paper reflects major themes from the conference, the now completed projects, and findings from scientific literature to propose a set of recommendations for addressing financial hardship as part of cancer care delivery. Recommendations include the following principles. Healthcare systems should implement financial hardship screening using validated, culturally appropriate tools, considering patient literacy and language needs. Screening programs should be universal with assessments repeated over time. Financial navigation services should be available to help patients manage direct and indirect costs of care, access financial assistance and navigate employment-related challenges. Financial navigators should receive specialized training to build their knowledge of healthcare billing, insurance, financial assistance, and patient advocacy while also preparing them to support patients and leverage local and regional resources. A multidisciplinary care team approach should be applied to developing and implementing financial hardship screening and navigation services. Finally, health systems should harmonize information technology and workflows across departments involved in screening and financial navigation service delivery and automate screening, referral, and care team notification processes. Future research should address outstanding knowledge gaps, including the optimal interval for screening, how to identify patient needs early to mitigate downstream financial hardship, and the ideal components and timing of financial navigation for different settings and populations.
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplemental Table 5 evaluates a dose response of healthcare utilization characterized by racial and economic residential segregation percentiles
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplemental Table 5 evaluates a dose response of healthcare utilization characterized by racial and economic residential segregation percentiles
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 11 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Table 11 shows a preliminary causal mediation analysis examining the association between ICE-race-income and healthcare utilization
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 11 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Table 11 shows a preliminary causal mediation analysis examining the association between ICE-race-income and healthcare utilization
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Results from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
These are results from the supplementary analysis and slo includes the supplementary figure legends
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Results from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
These are results from the supplementary analysis and slo includes the supplementary figure legends
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Data from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Background:Racialized economic segregation is linked to higher cancer-specific mortality; however, its impact on healthcare utilization (HCU) remains unclear. This study used the metric Index of Concentration at the Extremes (ICE) and evaluated the association between racial residential segregation (ICErace), racialized economic segregation (ICErace + income), and HCU among patients with breast cancer receiving chemotherapy.Methods:Patients ≥18 years who received chemotherapy and surgical management for stage I to III breast cancer (2012–2020) were identified in the electronic health record. Census tract–level ICErace and ICErace + income were derived from the 2008 to 2012 American Community Survey. HCU was defined as hospitalizations or emergency room visits during chemotherapy. General estimating equations with robust variance estimated associations between segregation indices and HCU. Mediation analyses examined the effect of ICErace + income on HCU.Results:Among 2,037 women (mean age, 53.7 ± 11.9 years), 10.6% were Black, 84.6% were White, and 4.8% were other. Higher concentrations of White residents were associated with reduced HCU risk [ICErace fifth quintile; risk ratio (RR) = 0.44; 95% confidence interval (CI), 0.32–0.59; reference: first quintile). A significant interaction was observed between ICErace and race (P = 0.009). The relationship between ICErace + income and HCU was nonlinear: HCU risk decreased progressively from the fifth percentile (RR = 0.97; 95% CI, 0.92–0.99) to the 63rd percentile (RR = 0.69; 95% CI, 0.49–0.99). Most of the ICErace + income effect on HCU was direct (OR = 0.88; 95% CI, 0.83–0.93), with minimal mediation by comorbidities (2.0%).Conclusions:Residence in racially and economically segregated census tracts is associated with greater HCU.Impact:These findings highlight structural racism as a determinant of cancer treatment burden, emphasizing the importance of neighborhood context in disparities and care delivery.
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Background:Racialized economic segregation is linked to higher cancer-specific mortality; however, its impact on healthcare utilization (HCU) remains unclear. This study used the metric Index of Concentration at the Extremes (ICE) and evaluated the association between racial residential segregation (ICErace), racialized economic segregation (ICErace + income), and HCU among patients with breast cancer receiving chemotherapy.Methods:Patients ≥18 years who received chemotherapy and surgical management for stage I to III breast cancer (2012–2020) were identified in the electronic health record. Census tract–level ICErace and ICErace + income were derived from the 2008 to 2012 American Community Survey. HCU was defined as hospitalizations or emergency room visits during chemotherapy. General estimating equations with robust variance estimated associations between segregation indices and HCU. Mediation analyses examined the effect of ICErace + income on HCU.Results:Among 2,037 women (mean age, 53.7 ± 11.9 years), 10.6% were Black, 84.6% were White, and 4.8% were other. Higher concentrations of White residents were associated with reduced HCU risk [ICErace fifth quintile; risk ratio (RR) = 0.44; 95% confidence interval (CI), 0.32–0.59; reference: first quintile). A significant interaction was observed between ICErace and race (P = 0.009). The relationship between ICErace + income and HCU was nonlinear: HCU risk decreased progressively from the fifth percentile (RR = 0.97; 95% CI, 0.92–0.99) to the 63rd percentile (RR = 0.69; 95% CI, 0.49–0.99). Most of the ICErace + income effect on HCU was direct (OR = 0.88; 95% CI, 0.83–0.93), with minimal mediation by comorbidities (2.0%).Conclusions:Residence in racially and economically segregated census tracts is associated with greater HCU.Impact:These findings highlight structural racism as a determinant of cancer treatment burden, emphasizing the importance of neighborhood context in disparities and care delivery.